FR2966249B1 - TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS - Google Patents

TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS

Info

Publication number
FR2966249B1
FR2966249B1 FR1058459A FR1058459A FR2966249B1 FR 2966249 B1 FR2966249 B1 FR 2966249B1 FR 1058459 A FR1058459 A FR 1058459A FR 1058459 A FR1058459 A FR 1058459A FR 2966249 B1 FR2966249 B1 FR 2966249B1
Authority
FR
France
Prior art keywords
tumorigenesis
biomarkers
applications
obtaining anti
metastatic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1058459A
Other languages
French (fr)
Other versions
FR2966249A1 (en
Inventor
Jean-Marie Blanchard
Benedicte Lemmers
Nawal Bendris
Nikola Arsic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Montpellier 2 Sciences et Techniques filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1058459A priority Critical patent/FR2966249B1/en
Priority to PCT/FR2011/000559 priority patent/WO2012052629A2/en
Publication of FR2966249A1 publication Critical patent/FR2966249A1/en
Application granted granted Critical
Publication of FR2966249B1 publication Critical patent/FR2966249B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4739—Cyclin; Prad 1

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR1058459A 2010-10-18 2010-10-18 TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS Expired - Fee Related FR2966249B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1058459A FR2966249B1 (en) 2010-10-18 2010-10-18 TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS
PCT/FR2011/000559 WO2012052629A2 (en) 2010-10-18 2011-10-18 Tumourigenesis biomarkers and uses for obtaining anti-metastatic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1058459A FR2966249B1 (en) 2010-10-18 2010-10-18 TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS

Publications (2)

Publication Number Publication Date
FR2966249A1 FR2966249A1 (en) 2012-04-20
FR2966249B1 true FR2966249B1 (en) 2012-12-14

Family

ID=43919797

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1058459A Expired - Fee Related FR2966249B1 (en) 2010-10-18 2010-10-18 TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS

Country Status (2)

Country Link
FR (1) FR2966249B1 (en)
WO (1) WO2012052629A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526490C (en) * 2003-05-19 2014-03-04 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
WO2009154790A2 (en) * 2008-06-20 2009-12-23 University Of Massachusetts Novel metastasis suppresor genes and uses thereof

Also Published As

Publication number Publication date
FR2966249A1 (en) 2012-04-20
WO2012052629A2 (en) 2012-04-26
WO2012052629A3 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
BR112012012872A2 (en) "spiroindolinone pyrrolindins"
BR112012004569A2 (en) "foreground object tracking"
BRPI1015540A2 (en) '' substituted 1-cyanoethylheterocyclylcarboxamide compound 750 ''
BRPI1014706A2 (en) indication of local internet protocol access capability
FR2948574B1 (en) PROBE FOR TRANSANAL IRRIGATION
BR112012004444A2 (en) "laryngoscope"
BRPI0820978A2 (en) Communication of visual change content
BR112012003701A2 (en) "new quinoline-hepcidin antagonists"
FR2956074B1 (en) TRAIN TRAIN
FR2968538B1 (en) PROSTHETIC FOR LOWER MEMBER
FR2967297B1 (en) REDUCTION OF OXIDE FORMATION ON A BRASURE
BRPI1014349A2 (en) "smart monitor"
FR2960418B1 (en) GLENOIDAL ASSEMBLY FOR SHOULDER PROSTHESIS
FR2956549B1 (en) IMAGE CONVERTER
BRPI1009730A2 (en) "container"
FR2962879B1 (en) BIOFERTILISATION OF A CULTURE VIA AZOTOBACTERIZATION OF THE PREVIOUS CULTURE
FR2958452B1 (en) JUNCTION TERMINATION EXTENSION RINGS
FR2980272B1 (en) CHARACTERIZATION OF THE GIGUE OF A CLOCK SIGNAL
FR2935165B1 (en) WATERTIGHT RING
FR2966249B1 (en) TUMORIGENESIS BIOMARKERS AND APPLICATIONS FOR OBTAINING ANTI-METASTATIC COMPOUNDS
BRPI1012632A2 (en) "sealed mixer"
FR2943852B1 (en) SHADOW DETECTOR
FR2947620B1 (en) FOOT FOR GEOTHERMAL PROBE
FR2942493B1 (en) SLIDING OPENING AMOUNT
BRPI1013017A2 (en) "17beta-alkyl-17alpha-oxystratrienes"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140630